Panacea Biotec terminates MoU with Refana for COVID-19 vaccine
The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid 19 vaccine
Roll-out plan of Sputnik-V prompts worries about virus mutation
Viruses are known for their ability to mutate all the time - and often this has little or no impact on the risk posed to people
40 per cent participants enrolled for COVID-19 vaccine trial: Moderna
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September
EU, CureVac may sign deal for 225 million doses of COVID-19 vaccine
CureVac said it could start large-scale human trials on its vaccine in the last quarter of this year based on results of its…
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR
Normally the final trial takes about six to nine months
WHO cautions against to ‘vaccine nationalism’
Urges all members to join COVAX vaccine effort
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate
The Johnson & Johnson vaccine candidate is the fourth to be approved for human trials in Brazil
India in talks with developer of Russian COVID-19 vaccine: The Indian Express
Russian regulators recently approved the Sputnik V vaccine developed by the Gamaleya Research Institute of Epidemiology and…
Race to find a viable vaccine: Can Indian firms rise to the challenge?
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…
CanSino gets COVID-19 vaccine patent from China’s IP regulator
As per reports by state media the patent was issued on August 11